Wallet Drug Company has just recently raised money abroad for the first time in the history of the firm. Prior to the recent equity issue abroad, the firm had a D/V ratio of 40%, an effective tax rate of 30%, a before-tax cost of debt of 9%, and a domestic beta of 1.3. The expected return on the market portfolio was 13% and the risk-free rate was 5%. After the equity issue, Wallet Drug has a D/V ratio of 50%, their after-tax cost of debt has not changed, nor has the effective tax rate, the firm's international beta is 1.0, the expected return on the market portfolio is only 12%, and the risk-free rate is still 5%. What is the change in the firm's WACC after the international equity issue?
A) 2.61%
B) 1.74%
C) 0.63%
D) There is no change in the firm's WACC.
Correct Answer:
Verified
Q1: One of the most important factors in
Q6: In theory, a MNE should support _
Q8: One of the most important factors in
Q9: Wallet Drug Company has just recently raised
Q13: For most firms, the cost of capital
Q13: Most financial theorists believe that the optimal
Q14: Given the following information, what is the
Q18: Investment banking services include which of the
Q18: Which of the following is the typical
Q26: Financial theory has at last provided us
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents